iShares Healthcare Innovation

Global healthcare companies

(DRDR)
£6.20
Previous business day’s close price
£1.29 (‑17.24%)
max available period
£5
£8.14

04 Jan 21
08 Nov 24

Details

ETF description

The iShares Healthcare Innovation ETF is designed to provide investors with exposure to companies that are at the forefront of technological advancements and innovation within the healthcare sector. By tracking the NYSE FactSet Global Healthcare Innovators index, this ETF focuses on firms involved in pioneering medical technologies, biotechnology, pharmaceuticals, and healthcare services, aiming to capture the growth potential from the latest advancements in healthcare.

Issuer details

iShares ETFs are issued and managed by BlackRock, the world’s largest asset management company.

With 800+ products globally and over $2trn in assets (as at June 2024), iShares ETFs are a flexible, low‑cost way for investors to gain exposure to various market segments, including fixed income, emerging markets and broad‑based indexes.

Index details

The Healthcare Innovation index offers specialized exposure to companies that are leading the way in healthcare advancements and breakthroughs. By focusing on innovative technologies, treatments, and solutions, the index aims to deliver growth potential and investment opportunities driven by the latest trends in healthcare. It serves as a valuable tool for investors seeking to capitalize on the transformative impact of healthcare innovation while benefiting from diversified exposure to cutting‑edge developments in the sector.

This ETF is in collections:

ETF Breakdown

argenx SE
2.0%
UCB SA
1.9%
Gilead Sciences, Inc.
1.9%
Illumina Inc
1.9%
Samsung Biologics Co Ltd
1.8%
Bristol‑Myers Squibb Co.
1.8%
Insulet Corporation
1.7%
Abbvie Inc
1.6%
Natera Inc
1.6%
Intuitive Surgical Inc
1.6%
Lonza Group AG
1.6%
Johnson & Johnson
1.6%
Boston Scientific Corp.
1.6%
Hologic, Inc.
1.6%
Novartis AG
1.6%
Agilent Technologies Inc.
1.6%
Exact Sciences Corp.
1.6%
Abbott Laboratories
1.6%
Medtronic Plc
1.6%
AMGEN Inc.
1.6%
IQVIA
1.6%
Pfizer Inc.
1.5%
Celltrion Inc
1.5%
Danaher Corp.
1.5%
Thermo Fisher
1.5%
BeiGene Ltd
1.5%
Sarepta Therapeutics Inc
1.4%
Bio‑Techne Corp
1.4%
GSK Plc
1.4%
Catalent Inc.
1.4%
Neurocrine Biosciences, Inc.
1.3%
Eisai Co Ltd
1.2%
Qiagen N.V.
1.2%
Sysmex Corporation
1.2%
Charles River Laboratories International Inc.
1.2%
Genmab
1.2%
Biogen Inc
1.2%
Merck & Co Inc
1.2%
Shimadzu Corporation
1.2%
Edwards Lifesciences Corp
1.1%
Exelixis Inc
1.1%
Medpace Holdings Inc
1.0%
Revolution Medicines Inc
1.0%
Bio‑Rad Laboratories Inc.
0.9%
Lantheus Holdings Inc
0.9%
Repligen Corp.
0.9%
Halozyme Therapeutics Inc.
0.9%
Pro Medicus
0.8%
Intra‑Cellular Therapies Inc
0.8%
Dexcom Inc
0.8%
Sartorius AG
0.8%
Zealand Pharma A/S.
0.8%
Biomerieux
0.7%
Maximus Inc.
0.7%
Ionis Pharmaceuticals Inc
0.7%
Siegfried Holding AG
0.6%
Alkermes plc
0.6%
Ipsen
0.6%
Moderna Inc
0.6%
Asahi Intecc Co. Ltd.
0.5%
Sectra Class B
0.5%
Tecan Group AG
0.5%
Akeso Inc
0.4%
BridgeBio Pharma Inc
0.4%
Axonics Inc
0.4%
Denali Therapeutics Inc
0.4%
TG Therapeutics Inc
0.4%
Axsome Therapeutics Inc
0.4%
Corvel Corp.
0.4%
Neogen Corp.
0.4%
Arcellx Inc
0.4%
Diasorin S.p.A.
0.4%
LivaNova PLC
0.4%
PTC Therapeutics Inc
0.4%
Evolent Health Inc
0.3%
R1 Rcm Inc
0.3%
Merus N.V
0.3%
Rhythm Pharmaceuticals Inc.
0.3%
SK Biopharmaceuticals Co. Ltd.
0.3%
Elekta AB (publ)
0.3%
Guardant Health Inc
0.3%
Bachem Holding AG
0.3%
Catalyst Pharmaceuticals Inc
0.3%
Tandem Diabetes Care Inc
0.3%
Twist Bioscience Corp
0.3%
Veracyte Inc
0.3%
Apollo Medical Holdings Inc
0.3%
Bavarian Nordic A/S
0.3%
Geron Corp.
0.3%
Ideaya Biosciences Inc
0.3%
Lion Biotechnologies Inc
0.3%
JEOL Ltd.
0.3%
Myriad Genetics, Inc.
0.3%
HUTCHMED (China) Limited
0.3%
QuidelOrtho Corporation
0.3%
H. Lundbeck AS
0.2%
Beam Therapeutics Inc
0.2%
Nurix Therapeutics Inc
0.2%
Sawai Group Holdings Co Ltd
0.2%
Supernus Pharmaceuticals Inc
0.2%
Acadia Pharmaceuticals Inc
0.2%
Ligand Pharmaceuticals, Inc.
0.2%
NovoCure Ltd
0.2%
Fortrea Holdings Inc
0.2%
10x Genomics Inc
0.2%
Arvinas Operations Inc
0.2%
Biocryst Pharmaceuticals Inc.
0.2%
Novavax, Inc.
0.2%
Atricure Inc
0.2%
Caredx Inc
0.2%
Dynavax Technologies Corp.
0.2%
Harmony Biosciences Holdings Inc
0.2%
United Laboratories International Holdings Ltd.
0.2%
Integra Lifesciences Holdings Corp
0.2%
Certara Inc
0.1%
Galapagos NV
0.1%
Oxford Nanopore Technologies Plc
0.1%
Xencor Inc
0.1%
Neuren Pharmaceuticals Ltd
0.1%
Recursion Pharmaceuticals Inc
0.1%
Xvivo Perfusion AB
0.1%
ABL Bio Inc.
0.1%
SK bioscience Co. Ltd.
0.1%
Schrodinger Inc
0.1%
ANI Pharmaceuticals Inc
0.1%
Chemometec AS
0.1%
Maravai LifeSciences Holdings Inc
0.1%
Peptron Inc.
0.1%
Pharmamar S.A.
0.1%
Castle Biosciences Inc
0.1%
Evotec SE
0.1%
Prothena Corporation plc
0.1%
Zymeworks Inc
0.1%
Keymed Biosciences Inc.
0.1%
Relay Therapeutics Inc
0.1%
ST Pharm Co Ltd
0.1%
Seegene Inc
0.1%
Vir Biotechnology Inc
0.1%
Arcus Biosciences Inc
< 0.1%
Avid Bioservices Inc
< 0.1%
Cytek BioSciences Inc
< 0.1%
ImmunityBio Inc
< 0.1%
Lunit Inc
< 0.1%
Adaptive Biotechnologies Corp
< 0.1%
Axogen Inc.
< 0.1%
BioArctic AB
< 0.1%
AbCellera Biologics Inc
< 0.1%
AnaptysBio Inc
< 0.1%
Pacific Biosciences of California Inc
< 0.1%
Pharming Group N.V.
< 0.1%
Polaris Group
< 0.1%
Roche Holding AG
< 0.1%
Tobii Dynavox AB
< 0.1%
Y‑Mabs Therapeutics Inc
< 0.1%
Arcturus Therapeutics Holdings Inc
< 0.1%
Eiken Chemical Co Ltd
< 0.1%
Japan Lifeline Co Ltd
< 0.1%
Quanterix Corp
< 0.1%
Simulations Plus Inc.
< 0.1%
4D Molecular Therapeutics Inc
< 0.1%
Alector Inc
< 0.1%
Allogene Therapeutics Inc
< 0.1%
CompuGroup Medical SE & Co. KgaA
< 0.1%
Regenxbio Inc
< 0.1%
SD Biosensor Inc.
< 0.1%
Sage Therapeutics Inc
< 0.1%
Fate Therapeutics Inc
< 0.1%
ITeos Therapeutics Inc
< 0.1%
Mersana Therapeutics Inc
< 0.1%
Orasure Technologies Inc.
< 0.1%
RemeGen Co. Ltd.
< 0.1%
Shanghai Junshi Biosciences Co Ltd
< 0.1%
Shinpoong Pharmaceutical
< 0.1%
Stoke Therapeutics Inc
< 0.1%
Takara Bio Inc.
< 0.1%
UroGen Pharma Ltd
< 0.1%
Vanda Pharmaceuticals Inc
< 0.1%
Accolade Inc
< 0.1%
I‑Sens USA Inc
< 0.1%
Lyell Immunopharma Inc
< 0.1%
Macrogenics Inc
< 0.1%
Sillajen Biotherapeutics Inc
< 0.1%
Sutro Biopharma Inc
< 0.1%
Valneva SE
< 0.1%
Venus Medtech (Hangzhou) Inc.
< 0.1%
ATAI Life Sciences N.V.
< 0.1%
Caribou Biosciences Inc
< 0.1%
Cellivery Therapeutics Inc.
< 0.1%
Idorsia Ltd
< 0.1%
Nevro Corp
< 0.1%
PHC Holdings Corporation
< 0.1%
uniQure N.V.
< 0.1%
Agenus Inc
< 0.1%
Nkmax Co. Ltd
< 0.1%
Peptron Inc Rights
< 0.1%
Others
0.4%
£6.20
Previous business day’s close price

Capital at risk

Why InvestEngine

Unbeatable value

From commission‑free investing, to zero‑ISA fees, we’re proud of our low fees.
Here's how we're able to do it

Choice of 700+ ETFs

Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
View our ETF range

Actionable insights

Know exactly which companies, sectors and regions are in your portfolio.

Powerful automation

Grow your wealth the easy way with automated investing features

Easy diversification

Fractional investing lets you put as little as £1 in any ETF.

DIY or Managed

Build and manage your own portfolio or leave it to us.
ETFs have spreads and annual charges and come with risks like market volatility, liquidity, and concentration, and may not always accurately track their index. Past performance and forecasts are not reliable indicators of future results. The value of your investments, including any income, can rise or fall. You may get back less than you originally invested.
Whenever you invest, your capital is at risk
This could mean the value of your investments goes down as well as up.
Understand more about investment risk.
© InvestEngine Limited 2024. All rights reserved.